01.06.2012 • NewsChemtrixMergers & Acquisitions (M&A)R&D

ESK Ceramics Acquires Interest in Chemtrix

ESK Ceramics, Germany, and Chemtrix, The Netherlands, jointly announced that ESK has acquired a minority interest in Chemtrix for an undisclosed amount.

Chemtrix develops and sells equipment and services based on the concept of executing R&D and process development in revolutionary micro reactors with a direct scale to kg-quantity production in mid-size reactors.

ESK is a supplier of flow chemistry reactors suitable to produce on an industrial scale. With this cooperation the companies are able to offer a complete product portfolio of scalable flow chemistry equipment and services to the pharmaceutical and fine chemical industry.

 

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read